13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001009258
申报总市值
US$95.9亿
US$95.9亿
123 檔
20.7%
在 Q1 2025 的 13F 官方备案中，Deerfield Management Company, L.p. 管理的美股投资组合规模来到 US$95.9亿，整体持股档数为 123 档。
在 Q1 2025，Deerfield Management Company, L.p. 展现出较为审慎的避险与获利了结姿态。本季共减仓 3 个仓位并完全清仓 114 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，Deerfield Management Company, L.p. 的前 5 大核心持股（包含 NUVL, VTRS, IART 0.5 08-15-25 等）合计占整体申报市值的 20.7%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NUVL | Nuvalent Inc-a | 股票-其他 | 25.19% | +1.37% | — | |
| 2 | VTRS | Viatris Inc | 股票-医疗保健 | 4.13% | +0.13% | -0.02% | |
| 3 | IART 0.5 08-15-25债券 | Integra Lifesciences Hld | 债券 | 3.38% | — | — | |
| 4 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 3.25% | -0.95% | EXIT | |
| 5 | CNC | Centene CORP | 股票-医疗保健 | 3.20% | +0.99% | — | |
| 6 | OSCR | Oscar Health Inc - Class A | 股票-医疗保健 | 3.06% | — | +0.05% | |
| 7 | ✓ | Merus N V | 股票-其他 | 2.64% | — | +6.77% | |
| 8 | SPRY | Ars Pharmaceuticals Inc | 股票-其他 | 2.61% | -0.08% | — | |
| 9 | ACCD 0.5 04-01-26债券 | Accolade Inc | 债券 | 2.58% | — | — | |
| 10 | ALNY 1 09-15-27债券 | Alnylam Pharmaceuticals | 债券 | 2.50% | — | — | |
| 11 | RVMD | Revolution Medicines Inc | 股票-医疗保健 | 2.32% | +2.03% | +1.81% | |
| 12 | MIRM 4 05-01-29债券 | Mirum Pharmaceuticals | 债券 | 2.26% | -2.47% | EXIT | |
| 13 | AHCO | Adapthealth CORP | 股票-其他 | 2.08% | -0.36% | — | |
| 14 | INDV | Indivior Pharmaceuticals, Inc. | 股票-其他 | 1.99% | — | +18.96% | |
| 15 | BKD | Brookdale Senior Living Inc | 股票-其他 | 1.93% | +0.07% | — | |
| 16 | ALHC | Alignment Healthcare Inc | 股票-其他 | 1.68% | — | -37.47% | |
| 17 | UTHR | United Therapeutics CORP | 股票-医疗保健 | 1.68% | -0.62% | — | |
| 18 | PFE | Pfizer Inc | 股票-医疗保健 | 1.67% | -0.25% | — | |
| 19 | NAMS | NewAmsterdam Pharma Company N.V. | 股票-其他 | 1.66% | -0.10% | -4.88% | |
| 20 | CPRX | Catalyst Pharmaceuticals Inc | 股票-医疗保健 | 1.64% | -1.15% | EXIT | |
| 21 | DVAX | Dynavax Technologies CORP | 股票-其他 | 1.33% | — | -0.04% | |
| 22 | BAX | Baxter International Inc | 股票-医疗保健 | 1.30% | — | — | |
| 23 | LEGN | Legend Biotech Corp-adr | 股票-其他 | 1.17% | +0.81% | +12.36% | |
| 24 | BIO | Bio-rad Laboratories-a | 股票-医疗保健 | 1.09% | -0.05% | +49.08% | |
| 25 | IDYA | Ideaya Biosciences Inc | 股票-其他 | 1.06% | +0.46% | +19.43% | |
| 26 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 0.90% | — | — | |
| 27 | LRMR | Larimar Therapeutics Inc | 股票-其他 | 0.90% | -0.76% | — | |
| 28 | EHABUSD | Enhabit Inc | 股票-其他 | 0.87% | -0.79% | EXIT | |
| 29 | ALNY | Alnylam Pharmaceuticals Inc | 股票-医疗保健 | 0.77% | -0.06% | -0.13% | |
| 30 | BCRX | Biocryst Pharmaceuticals Inc | 股票-其他 | 0.77% | -0.12% | -36.28% | |
| 31 | IRON | Disc Medicine Inc | 股票-其他 | 0.77% | — | +30.28% | |
| 32 | CNMD | Conmed CORP | 股票-其他 | 0.73% | — | -0.16% | |
| 33 | LNTH 2.625 12-15-27债券 | Lantheus Holdings Inc | 债券 | 0.70% | — | — | |
| 34 | NVST | Envista Holdings CORP | 股票-医疗保健 | 0.69% | -0.05% | +98.83% | |
| 35 | INSM | Insmed Inc | 股票-医疗保健 | 0.69% | — | — | |
| 36 | EMBC | Embecta CORP | 股票-医疗保健 | 0.68% | -0.17% | -16.82% | |
| 37 | CMRXEUR | Chimerix Inc | 股票-其他 | 0.63% | — | — | |
| 38 | PHVS | Pharvaris N.V. | 股票-其他 | 0.63% | +0.18% | — | |
| 39 | CGEM | Cullinan Therapeutics Inc | 股票-其他 | 0.58% | -0.06% | EXIT | |
| 40 | INMD | InMode Ltd. | 股票-其他 | 0.55% | — | — | |
| 41 | PHR | Phreesia Inc | 股票-其他 | 0.51% | — | -20.60% | |
| 42 | VERA | Vera Therapeutics Inc | 股票-其他 | 0.50% | -0.02% | — | |
| 43 | IMCR 2.5 02-01-30债券 | Immunocore Holdings | 债券 | 0.50% | -0.04% | — | |
| 44 | LQDA | Liquidia CORP | 股票-其他 | 0.47% | — | — | |
| 45 | DAWNGBX | Day One Biopharmaceuticals I | 股票-其他 | 0.46% | -0.94% | EXIT | |
| 46 | PRAX | Praxis Precision Medicines I | 股票-其他 | 0.46% | -0.30% | — | |
| 47 | LNTH | Lantheus Holdings Inc | 股票-医疗保健 | 0.46% | +0.13% | — | |
| 48 | SVRA | Savara Inc | 股票-其他 | 0.44% | — | — | |
| 49 | CGON | Cg Oncology Inc | 股票-其他 | 0.41% | — | -0.11% | |
| 50 | ✓ | Establishment Labs Holdings In | 股票-其他 | 0.40% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | NBIX | Neurocrine Biosciences Inc | +2% | +72.74% | 加仓 |
| 2 | CNC | Centene CORP | +1.9% | — | 加仓 |
| 3 | BKD | Brookdale Senior Living Inc | +1.5% | — | 加仓 |
| 4 | RVMD | Revolution Medicines Inc | +1.4% | +1.81% | 加仓 |
| 5 | INSM | Insmed Inc | +0.6% | — | 加仓 |
| 6 | CMRXEUR | Chimerix Inc | +0.4% | — | 加仓 |
| 7 | PHVS | Pharvaris N.V. | +0.3% | — | 加仓 |
| 8 | DAWNGBX | Day One Biopharmaceuticals I | +0.1% | +14.05% | 加仓 |
| 9 | CGEM | Cullinan Therapeutics Inc | +0.1% | +14.25% | 加仓 |
| 10 | DCTH | Delcath Systems Inc | +0.1% | — | 加仓 |
| 11 | COGT | Cogent Biosciences Inc | +0.1% | +0.11% | 加仓 |
| 12 | BCRX | Biocryst Pharmaceuticals Inc | 0% | -36.28% | 加仓 |
| 13 | BFLYW | Butterfly Network Inc -cw25 | -0.1% | — | 不变 |
| 14 | TALK | Talkspace Inc | -0.1% | — | 减仓 |
| 15 | LRMR | Larimar Therapeutics Inc | -0.1% | — | 加仓 |
| 16 | DYN | Dyne Therapeutics Inc | -0.1% | +86.48% | 加仓 |
| 17 | ANNX | Annexon Inc | -0.2% | — | 不变 |
| 18 | ALEC | Alector Inc | -0.4% | -1.10% | 不变 |
| 19 | EWTX | Edgewise Therapeutics Inc | -0.6% | — | 减仓 |
| 20 | NUVB | Nuvation Bio Inc | -0.6% | +125.37% | 减仓 |
| 21 | VTRS | Viatris Inc | -0.7% | -0.02% | 加仓 |
| 22 | LUNG | Pulmonx CORP | -1.2% | +23.15% | 加仓 |
| 23 | AHCO | Adapthealth CORP | -1.5% | — | 加仓 |
| 24 | NUVL | Nuvalent Inc-a | — | NEW | 新建仓 |
| 25 | ✓ | Singular Genomics Systems In | — | EXIT | 清仓 |
| 26 | NVTA 2 09-01-24债券 | Invitae CORP | — | EXIT | 清仓 |
| 27 | ✓ | Caremax Inc | — | EXIT | 清仓 |
| 28 | IART 0.5 08-15-25债券 | Integra Lifesciences Hld | — | NEW | 新建仓 |
| 29 | AERI 1.5 10-01-24债券 | Aerie Pharmaceuticals | — | EXIT | 清仓 |
| 30 | OSCR | Oscar Health Inc - Class A | — | NEW | 新建仓 |
| 31 | GKOS 2.75 06-15-27债券 | Glaukos CORP | — | EXIT | 清仓 |
| 32 | NTRA 2.25 05-01-27债券 | Natera Inc | — | EXIT | 清仓 |
| 33 | ✓ | Merus N V | — | NEW | 新建仓 |
| 34 | SPRY | Ars Pharmaceuticals Inc | — | NEW | 新建仓 |
| 35 | BBIO 2.5 03-15-27债券 | Bridgebio Pharma Inc | — | EXIT | 清仓 |
| 36 | ACCD 0.5 04-01-26债券 | Accolade Inc | — | NEW | 新建仓 |
| 37 | ALNY 1 09-15-27债券 | Alnylam Pharmaceuticals | — | NEW | 新建仓 |
| 38 | ORGO | Organogenesis Holdings Inc | — | EXIT | 清仓 |
| 39 | MIRM 4 05-01-29债券 | Mirum Pharmaceuticals | — | NEW | 新建仓 |
| 40 | NVST 2.375 06-01-25债券 | Envista Holdings CORP | — | EXIT | 清仓 |
| 41 | GMED 1 06-01-23债券 | Nuvasive Inc | — | EXIT | 清仓 |
| 42 | INDV | Indivior Pharmaceuticals, Inc. | — | NEW | 新建仓 |
| 43 | ALHC | Alignment Healthcare Inc | — | NEW | 新建仓 |
| 44 | UTHR | United Therapeutics CORP | — | NEW | 新建仓 |
| 45 | PFE | Pfizer Inc | — | NEW | 新建仓 |
| 46 | NAMS | NewAmsterdam Pharma Company N.V. | — | NEW | 新建仓 |
| 47 | CPRX | Catalyst Pharmaceuticals Inc | — | NEW | 新建仓 |
| 48 | PODD 0.375 09-01-26债券 | Insulet Corporation | — | EXIT | 清仓 |
| 49 | APLS 3.5 09-15-26债券 | Apellis Pharmaceuticals | — | EXIT | 清仓 |
| 50 | AFIB | Acutus Medical Inc | — | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案，Deerfield Management Company, L.p. 在 Q1 2025 季度的美股持仓总市值约为 US$95.9亿，共申报了 123 个公开持股仓位。
在 Q1 2025 季度，Deerfield Management Company, L.p. 按市值排列的前三大核心持股分别为：NUVL (25.2%)、VTRS (4.1%)、IART 0.5 08-15-25 (3.4%)。其中最大持股仓位 NUVL 占据整体投资组合约 25.2% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
NUVL
市值: US$12.8亿
本季最大获利了结 / 清仓标的
SINGULAR GENOMICS SYSTEMS IN
前期市值: US$2.5亿
在 Q1 2025 季度中，Deerfield Management Company, L.p. 共进行了 197 项持仓异动，包含新建仓 63 个仓位、加仓 17 个仓位、减仓 3 个仓位以及清仓 114 个仓位。 其中最大新建仓标的为 NUVL。 本季清仓仓位包含 SINGULAR GENOMICS SYSTEMS IN。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。